Read the latest news from Saama.
Saama’s Gregory T. Simpson Shares Best Practices at Saama PM360 asked 10 life sciences marketing leaders about their favorite (and least favorite) martech in this
PharmaVoice’s “Last Magazine” Features Saama Founder and CEO To celebrate its shift from a monthly magazine to a daily news digest, the PharmaVOICE editorial team
CAMPBELL, CA – (November 19, 2021) – Saama Technologies, LLC. (“Saama”) today announced the appointment of six individuals to its Board of Directors. Saama board
Deriving Insights from Clinical Data Is as Simple as Asking a Question In this contributed article for Applied Clinical Trials, Saama’s Srinivasan Anandakumar (VP, Product
Point Solutions Are Only Band-Aid Fixes to Clinical Process Problems Implementing an AI-powered data analytics system has been a game-changer for Taiho Oncology. In this
A Seminal Moment for Life Sciences In this PharmaVOICE article, Saama’s Chief Strategy Officer Sagar Anisingaraju explains why sponsors and CROs that fail to adopt
As AI Continues to Entice Big Pharma, a Carlyle-Led Drugmaker Syndicate Shells Out $430M for Cloud Computing Player Pharma’s AI Revolution Takes Big Financial Step
Private Equity Group Gets Control of Campbell-Based Saama Technologies in $430M Deal Pharma Venture Funds See Value in Saama’s Leadership The Silicon Valley Business Journal
Carlyle and co-investors including Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund (“Merck GHI”), McKesson Ventures, Northpond Ventures, Pfizer Ventures, and Population Health Partners
